📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Genomic profiling of idiopathic peri-hilar cholangiocarcinoma reveals new targets and mutational pathways. (2023)

First Author: Quinn LM

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-023-33096-0

PubMed Identifier: 37095160

Publication URI: http://europepmc.org/abstract/MED/37095160

Type: Journal Article/Review

Volume: 13

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322